Distinct inhibitory effects of tacrolimus and cyclosporin A on calcineurin phosphatase activity

Masahide Fukudo, Ikuko Yano, Satohiro Masuda, Masahiro Okuda, Ken Ichi Inui

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

We have compared the pharmacodynamic properties of calcineurin inhibitors tacrolimus and cyclosporin A in rats to clarify the different therapeutic drug monitoring strategy of both drugs in a clinical situation. In various tissue extracts, the inhibition of calcineurin activity by cyclosporin A was significantly greater than that by tacrolimus at the same drug concentration (1 μM) in the thymus, heart, liver, spleen, kidney, and testis (p < 0.05). The time profiles of blood concentrations and calcineurin activity in whole blood were examined after single or repeated administration of each drug in rats. A substantial time delay in the inhibition was observed following the single administration of tacrolimus or cyclosporin A, resulting in an anticlockwise hysteresis in the relationship between blood concentrations and calcineurin inhibition in whole blood. In contrast, such a hysteresis loop diminished after the repeated administration of each drug, and the recovery rate of calcineurin activity was greater for the inhibition induced by cyclosporin A than by tacrolimus. Furthermore, tacrolimus produced a comparable inhibition of calcineurin activity in whole blood at lower blood concentrations than cyclosporin A. Overall, the effect compartment model well described the time profiles of calcineurin activity in whole blood after the single and repeated administrations of each drug. These findings suggest that the properties of calcineurin inhibition differ between tacrolimus and cyclosporin A. Distinct pharmacodynamics may partly contribute to the therapeutic drug monitoring strategy in transplant patients receiving calcineurin inhibitors.

Original languageEnglish
Pages (from-to)816-825
Number of pages10
JournalJournal of Pharmacology and Experimental Therapeutics
Volume312
Issue number2
DOIs
Publication statusPublished - Feb 1 2005
Externally publishedYes

Fingerprint

Calcineurin
Tacrolimus
Cyclosporine
Pharmaceutical Preparations
Drug Monitoring
Tissue Extracts
calcineurin phosphatase
Thymus Gland
Testis
Spleen
Transplants
Kidney
Liver

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Pharmacology

Cite this

Distinct inhibitory effects of tacrolimus and cyclosporin A on calcineurin phosphatase activity. / Fukudo, Masahide; Yano, Ikuko; Masuda, Satohiro; Okuda, Masahiro; Inui, Ken Ichi.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 312, No. 2, 01.02.2005, p. 816-825.

Research output: Contribution to journalArticle

Fukudo, Masahide ; Yano, Ikuko ; Masuda, Satohiro ; Okuda, Masahiro ; Inui, Ken Ichi. / Distinct inhibitory effects of tacrolimus and cyclosporin A on calcineurin phosphatase activity. In: Journal of Pharmacology and Experimental Therapeutics. 2005 ; Vol. 312, No. 2. pp. 816-825.
@article{4d1197abd6e24478a3fd3d83e4aa7087,
title = "Distinct inhibitory effects of tacrolimus and cyclosporin A on calcineurin phosphatase activity",
abstract = "We have compared the pharmacodynamic properties of calcineurin inhibitors tacrolimus and cyclosporin A in rats to clarify the different therapeutic drug monitoring strategy of both drugs in a clinical situation. In various tissue extracts, the inhibition of calcineurin activity by cyclosporin A was significantly greater than that by tacrolimus at the same drug concentration (1 μM) in the thymus, heart, liver, spleen, kidney, and testis (p < 0.05). The time profiles of blood concentrations and calcineurin activity in whole blood were examined after single or repeated administration of each drug in rats. A substantial time delay in the inhibition was observed following the single administration of tacrolimus or cyclosporin A, resulting in an anticlockwise hysteresis in the relationship between blood concentrations and calcineurin inhibition in whole blood. In contrast, such a hysteresis loop diminished after the repeated administration of each drug, and the recovery rate of calcineurin activity was greater for the inhibition induced by cyclosporin A than by tacrolimus. Furthermore, tacrolimus produced a comparable inhibition of calcineurin activity in whole blood at lower blood concentrations than cyclosporin A. Overall, the effect compartment model well described the time profiles of calcineurin activity in whole blood after the single and repeated administrations of each drug. These findings suggest that the properties of calcineurin inhibition differ between tacrolimus and cyclosporin A. Distinct pharmacodynamics may partly contribute to the therapeutic drug monitoring strategy in transplant patients receiving calcineurin inhibitors.",
author = "Masahide Fukudo and Ikuko Yano and Satohiro Masuda and Masahiro Okuda and Inui, {Ken Ichi}",
year = "2005",
month = "2",
day = "1",
doi = "10.1124/jpet.104.074930",
language = "English",
volume = "312",
pages = "816--825",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "2",

}

TY - JOUR

T1 - Distinct inhibitory effects of tacrolimus and cyclosporin A on calcineurin phosphatase activity

AU - Fukudo, Masahide

AU - Yano, Ikuko

AU - Masuda, Satohiro

AU - Okuda, Masahiro

AU - Inui, Ken Ichi

PY - 2005/2/1

Y1 - 2005/2/1

N2 - We have compared the pharmacodynamic properties of calcineurin inhibitors tacrolimus and cyclosporin A in rats to clarify the different therapeutic drug monitoring strategy of both drugs in a clinical situation. In various tissue extracts, the inhibition of calcineurin activity by cyclosporin A was significantly greater than that by tacrolimus at the same drug concentration (1 μM) in the thymus, heart, liver, spleen, kidney, and testis (p < 0.05). The time profiles of blood concentrations and calcineurin activity in whole blood were examined after single or repeated administration of each drug in rats. A substantial time delay in the inhibition was observed following the single administration of tacrolimus or cyclosporin A, resulting in an anticlockwise hysteresis in the relationship between blood concentrations and calcineurin inhibition in whole blood. In contrast, such a hysteresis loop diminished after the repeated administration of each drug, and the recovery rate of calcineurin activity was greater for the inhibition induced by cyclosporin A than by tacrolimus. Furthermore, tacrolimus produced a comparable inhibition of calcineurin activity in whole blood at lower blood concentrations than cyclosporin A. Overall, the effect compartment model well described the time profiles of calcineurin activity in whole blood after the single and repeated administrations of each drug. These findings suggest that the properties of calcineurin inhibition differ between tacrolimus and cyclosporin A. Distinct pharmacodynamics may partly contribute to the therapeutic drug monitoring strategy in transplant patients receiving calcineurin inhibitors.

AB - We have compared the pharmacodynamic properties of calcineurin inhibitors tacrolimus and cyclosporin A in rats to clarify the different therapeutic drug monitoring strategy of both drugs in a clinical situation. In various tissue extracts, the inhibition of calcineurin activity by cyclosporin A was significantly greater than that by tacrolimus at the same drug concentration (1 μM) in the thymus, heart, liver, spleen, kidney, and testis (p < 0.05). The time profiles of blood concentrations and calcineurin activity in whole blood were examined after single or repeated administration of each drug in rats. A substantial time delay in the inhibition was observed following the single administration of tacrolimus or cyclosporin A, resulting in an anticlockwise hysteresis in the relationship between blood concentrations and calcineurin inhibition in whole blood. In contrast, such a hysteresis loop diminished after the repeated administration of each drug, and the recovery rate of calcineurin activity was greater for the inhibition induced by cyclosporin A than by tacrolimus. Furthermore, tacrolimus produced a comparable inhibition of calcineurin activity in whole blood at lower blood concentrations than cyclosporin A. Overall, the effect compartment model well described the time profiles of calcineurin activity in whole blood after the single and repeated administrations of each drug. These findings suggest that the properties of calcineurin inhibition differ between tacrolimus and cyclosporin A. Distinct pharmacodynamics may partly contribute to the therapeutic drug monitoring strategy in transplant patients receiving calcineurin inhibitors.

UR - http://www.scopus.com/inward/record.url?scp=13244279503&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13244279503&partnerID=8YFLogxK

U2 - 10.1124/jpet.104.074930

DO - 10.1124/jpet.104.074930

M3 - Article

VL - 312

SP - 816

EP - 825

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 2

ER -